Take part in “Module 3: The impact of BPH on sexual function”, the latest module of the online curriculum “Current challenges for optimal individualised management of LUTS/BPE patients”. Developed by the European School of Urology, the EAU Section of Female and Functional Urology, and the EAU Guidelines Male LUTS panel, this module combines top scientific content with evidence-based recommendations and real-life clinical practice experience.
The module will cover:
- New recommendations of the EAU Guidelines on the management of sexual health in patients undergoing BPH pharmacological treatment (e.g, 5PDI + alphablockers)
- Updates on best evidence available on 5ARI monotherapy impact on sexual function
- Latest evidence on the impact of 5ARI + alpha-blocker on sexual function
- Recent insights on PSA management in patients under 5ARI treatment, and more.
C. Gratzke, Freiburg (DE)
A. Salonia, Milan (IT)
Publication date: May 2021
Available languages: English
Topic: Functional Urology
CME: This webinar is accredited with 1 European CME credit (ECMEC®) upon your completion of the questionnaire after attending the live webinar
Duration: Approx. 60 – 90 minutes
This educational activity has been funded by GlaxoSmithKline. The educational programme of this online activity has been independently developed and approved by the European School of Urology, the EAU Section of Female and Functional Urology (ESFFU) and the EAU Guidelines.
CL code NP-GBL-UR-WCNT-210003
Date of preparation May 2021